Mutation of the Secys residue 266 in human type 2 selenodeiodinase alters 75Se incorporation without affecting its biochemical properties
- 1 May 1999
- Vol. 81 (5) , 535-538
- https://doi.org/10.1016/s0300-9084(99)80106-0
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Expression of the Type II Iodothyronine Deiodinase in Cultured Rat Astrocytes Is Selenium-dependentPublished by Elsevier ,1997
- Type 2 iodothyronine deiodinase is highly expressed in human thyroid.Journal of Clinical Investigation, 1996
- Molecular biological and biochemical characterization of the human type 2 selenodeiodinaseEndocrinology, 1996
- Cloning of the mammalian type II iodothyronine deiodinase. A selenoprotein differentially expressed and regulated in human and rat brain and other tissues.Journal of Clinical Investigation, 1996
- Knowing when not to stop: selenocysteine incorporation in eukaryotesTrends in Biochemical Sciences, 1996
- Translational termination efficiency in mammals is influenced by the base following the stop codon.Proceedings of the National Academy of Sciences, 1995
- Selenocysteine insertion or termination: factors affecting UGA codon fate and complementary anticodon:codon mutationsNucleic Acids Research, 1994
- Recognition of UGA as a selenocysteine codon in Type I deiodinase requires sequences in the 3′ untranslated regionNature, 1991
- Type I iodothyronine deiodinase is a selenocysteine-containing enzymeNature, 1991
- Functional characterization of the rat growth hormone promoter elements required for induction by thyroid hormone with and without a co-transfected β type thyroid hormone receptorPublished by Elsevier ,1989